Financial Data and Key Metrics Changes - First quarter revenue was $44.6 million, a modest increase of $200,000 or 1% compared to the prior year period, driven by growth in standard listings and display advertising [12][15] - Net income rose to $2.5 million from $2 million in the prior year, primarily due to mark-to-market adjustments on warrants and higher interest income [15] - Adjusted EBITDA for the first quarter was $10.1 million, exceeding expectations due to slightly higher revenue and lower expenses [15][16] - Cash from operations generated was $1.3 million, with a cash balance of $53.3 million, marking the seventh consecutive quarter of cash growth [15][16] Business Line Data and Key Metrics Changes - Growth in standard listings increased by $400,000, while display advertising grew by $800,000, offset by a $1 million decline in revenue from featured and deal listings [12][13] - Average monthly paying clients increased by 5% year over year to 5,179, but average monthly revenue per paying client declined to $2,871 from $2,997 [13] Market Data and Key Metrics Changes - Mature markets continue to show decreasing retail prices, leading to reduced cash flow for clients and impacting their ability to purchase services [8] - Emerging markets, while showing potential, remain subscale and do not compensate for challenges in mature markets [8] Company Strategy and Development Direction - The company is focused on disciplined execution, maintaining a lean cost structure, and driving ROI-driven investments [9] - Significant progress has been made in technology and product development, including improvements in data infrastructure and automation [10] - The marketing organization has been restructured to reconnect with the brand's heritage in the cannabis culture [10] Management's Comments on Operating Environment and Future Outlook - The regulatory environment remains challenging, with over-taxation and competition from unregulated hemp impacting the cannabis industry [5][6] - Management expresses cautious optimism about potential federal legalization, noting that a significant majority of Americans support it [7] - The company expects revenues for the second quarter to be approximately $45 million, with non-GAAP adjusted EBITDA estimated at $8 million [16] Other Important Information - GAAP operating expenses totaled $42 million, reflecting a 3% increase over the prior year, driven by higher general and administrative expenses [14] - The increase in G&A expenses included $2 million of non-recurring charges related to legal expenses and severance [14] - The company has no debt on its balance sheet, allowing for strategic investments despite ongoing industry challenges [15][16] Q&A Session Summary - No specific questions or answers were provided in the content regarding the Q&A session.

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Canopy Growth Corporation ("Canopy Growth Corporation" or the "Company") (NASDAQ: CGC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Canopy Growth Corporation investors who were adversely affected by alleged securities fraud between May 30, 2024 and February 6, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zl ...

Core Insights - Cronos Group Inc. reported a 28% year-over-year increase in net revenue for Q1 2025, reaching $32.3 million, with a 33% increase on a constant currency basis [1][11] - The company maintains a strong balance sheet with $838 million in total cash and cash equivalents and short-term investments [1] - PEACE NATURALS remains the leading cannabis brand in Israel, achieving record net revenue and market share [3][19] Financial Performance - Net revenue for Q1 2025 was $32,262 thousand, up from $25,288 thousand in Q1 2024, marking a $6,974 thousand increase [6][11] - Gross profit increased to $13,734 thousand in Q1 2025, a rise of $9,251 thousand from Q1 2024, resulting in a gross margin of 43% compared to 18% in the previous year [6][8] - Net income for Q1 2025 was $7,723 thousand, a significant improvement of $10,207 thousand from a loss of $2,484 thousand in Q1 2024 [8][11] Market Position and Brand Performance - The Spinach brand ranked as the second most popular brand in Canada with a 4.6% market share and third in the flower category with a 5.1% market share [13] - SOURZ by Spinach captured a 20% market share in the gummy category, making it the best-selling gummy brand in Canada [14] - Lord Jones Chocolate Fusions™ achieved a 9.6% market share, ranking as the third best-selling chocolate cannabis edible brand in Canada [16] Strategic Initiatives - Cronos GrowCo's expansion is on track for completion in Q2 2025, which is expected to significantly increase cultivation capacity and meet growing demand [2][22] - The company has authorized a share repurchase program of up to $50 million, expected to commence on May 14, 2025 [10] - New product launches in Q1 2025 include strain-specific cannabis oils under the PEACE NATURALS brand, aimed at enhancing product offerings in international markets [19][20] Regulatory Environment - An anti-dumping duty of up to 165% on Canadian medical cannabis imports into Israel was proposed but later vetoed, although the Ministry of Economy intends to pursue the duty process [23]

Core Insights - Verano Holdings Corp. reported its financial results for Q1 2025, showing a decrease in revenues and gross profit compared to previous quarters, primarily due to increased promotional activity and price compression in key markets [1][5][6] Financial Performance - Revenues for Q1 2025 were $210 million, down 5% year-over-year from $221 million in Q1 2024 and down 4% from $218 million in Q4 2024 [5][8] - Gross profit for Q1 2025 was $100 million, representing 47% of revenue, a decline from 51% in Q1 2024 and 49% in Q4 2024 [6][8] - The company reported a net loss of $12 million, or 5% of revenue, compared to a net loss of $5 million, or 2% of revenue, in Q1 2024 [10][8] - Adjusted EBITDA for Q1 2025 was $54 million, or 26% of revenue, down from $66 million, or 30% of revenue, in Q1 2024 [10][31] Operational Highlights - The company expanded its retail footprint by opening new dispensaries, bringing its total to 81 in Florida and 155 across 13 states [15] - Verano launched new products in response to market demand, including innovative vapes and pre-roll joints [15] - The company secured an additional $12 million in financing by leveraging its owned CPG real estate in Nevada and Arizona [15] Management Commentary - The CEO expressed satisfaction with the company's progress in executing strategic priorities, emphasizing innovation, automation, and operational efficiencies [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1]. Group 1: Allegations - The complaint alleges that Canopy Growth Corporation incurred significant costs related to the production of Claybourne pre-rolled joints during its product launch in Canada [1]. - It is claimed that these costs, along with indirect costs from Storz & Bickel vaporizer devices, negatively affected the company's gross margins and overall financial results [1]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and downplaying issues related to gross margins, leading to materially false and misleading public statements [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as May 30, 2024, to February 6, 2025, and shareholders are encouraged to register for participation [2]. - The deadline for shareholders to seek lead plaintiff status is June 3, 2025, with no cost or obligation to participate in the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - Tilray Brands is currently trading at its all-time low, having lost 94% of its value over the past five years, primarily due to the lack of marijuana legalization in the U.S. which investors had anticipated [1][4][10] Financial Performance - The company's total net revenue for the most recent quarter ended on February 28 was $185.8 million, reflecting a 1% decline [7] - Tilray reported an operating loss of $760 million, which included impairment charges of nearly $700 million [7] - The company burned through $5.8 million in cash from its day-to-day operations [7] Growth Strategy - Tilray has been pivoting towards alcohol to grow its top line, but this strategy has not generated sufficient growth to attract investors [5][6] - The company is exploring international cannabis markets and acquiring craft beer brands in the U.S. as potential growth avenues, but these efforts have not yielded significant results [6] Investment Considerations - The stock has been in a continuous decline, and buying it at a lower price has not proven to be a successful strategy [9] - Without a significant catalyst for growth or a clear path to profitability, the stock may not be a worthwhile investment at this time [10]

Core Viewpoint - Rubicon Organics Inc. has successfully closed a non-brokered private placement offering, raising approximately $4.5 million through the issuance of 10,227,265 units at a price of $0.44 per unit [1][2]. Group 1: Offering Details - Each unit consists of one common share and one-half of a common share purchase warrant, with warrants priced at $0.70 and valid for 24 months [2]. - The company paid finders' fees totaling approximately $100,467 and issued 228,335 finder warrants, also exercisable at $0.70 for 24 months [3]. - All units issued are not subject to a hold period under Canadian securities laws due to the exemption utilized [4]. Group 2: Board Participation - Members of the Board subscribed for a total of 3,410,545 units, generating approximately $1.5 million in gross proceeds [5]. - The participation of Board members is classified as a related party transaction, with the company relying on exemptions from formal valuation and minority shareholder approval requirements [5]. Group 3: Use of Proceeds - The net proceeds from the offering will be allocated for start-up and acquisition costs of the Hope Facility, pre-roll automation, capital investments, and general working capital [6]. - If the acquisition of the Hope Facility does not proceed, the funds may be redirected to other projects or working capital needs [6]. Group 4: Ownership Changes - Following the offering, Jesse McConnell's ownership increased from 21.13% to approximately 18.65% of the undiluted common shares outstanding [8][9]. - McConnell's total holdings now include 12,745,118 common shares, 325,000 stock options, 450,000 restricted share units, 140,459 deferred share units, and 250,000 warrants [9]. Group 5: Company Overview - Rubicon Organics Inc. is a leader in premium organic cannabis products, vertically integrated through its subsidiary Rubicon Holdings Corp [12]. - The company focuses on profitability through its premium cannabis flower and brand management, featuring brands like Simply Bare™ Organic and Wildflower™ [12][13].

Core Viewpoint - MariMed Inc. reported its financial results for Q1 2025, highlighting revenue growth driven by wholesale sales despite challenges in retail performance [1][2]. Financial Performance - Revenue for Q1 2025 was $38.0 million, a slight increase from $37.9 million in Q1 2024 [3]. - GAAP gross margin decreased to 40% from 43% year-over-year, while non-GAAP gross margin fell to 41% from 44% [3]. - The company reported a GAAP net loss of $5.4 million compared to a loss of $1.3 million in the same quarter last year [3]. - Non-GAAP adjusted EBITDA was $2.6 million, down from $4.7 million in Q1 2024, with a margin of 7% compared to 12% [3]. Operational Highlights - MariMed expanded its market presence by selling products into 70 new storefronts, with wholesale sales now accounting for 44% of total revenue [2]. - The company completed the acquisition of First State Compassion Center, enhancing its operational capabilities in Delaware [5][6]. - New product launches included the distribution of Nature's Heritage™ cannabis products in Illinois and the introduction of a new caramel chew under the Betty's Eddies™ brand [11]. Management Commentary - The CEO emphasized the company's commitment to building a leading consumer packaged goods company in the cannabis sector, focusing on brand distribution and operational efficiencies [2]. - The CFO noted that wholesale sales helped mitigate the impact of a weaker retail quarter and highlighted ongoing efforts to manage costs and explore new revenue streams [2]. Revenue Breakdown - Retail product sales were $20.8 million, down from $22.3 million in Q1 2024, while wholesale product sales increased to $16.8 million from $14.5 million [27]. - Other revenue sources contributed $0.4 million, down from $1.1 million in the previous year [27]. Balance Sheet Overview - As of March 31, 2025, total assets were $208.0 million, slightly up from $206.9 million at the end of 2024 [19][20]. - Current liabilities increased to $55.3 million from $48.7 million, reflecting higher accrued expenses and income taxes payable [20]. - Stockholders' equity decreased to $59.2 million from $59.9 million, primarily due to the net loss reported [20]. Future Outlook - The company plans to continue expanding its brand distribution and explore mergers and acquisitions as part of its growth strategy [2]. - Management remains focused on disciplined cost management and operational efficiencies to enhance shareholder value [2].

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Canopy Growth Corporation (NASDAQ: CGC). Shareholders who purchased shares of CGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/canopy-growth-corporation-loss-submission-form-2/?id=147121&from=3 CLASS PE ...

LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, announced today that it plans to release its financial results for the first quarter ended March 31st, 2025, on May 14th, 2025, aftermarket.Planet 13 will host a conference call on May 14th, 2025, to discuss its first quarter financial results and provide investors with key business highlights, strategy, and outlook. The c ...